Respiratory tract infection: an unfamiliar risk factor in high-altitude pulmonary edema
Briefings in Functional Genomics · 18.01.2024 · 23 (1) · 38-45
DOI: 10.1093/bfgp/elac048 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Briefings in Functional Genomics, online erschienen am 10.12.2022. Verfasst von Raushni Choudhary und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardio Respiratory Disease Unit, CSIR-Institute of Genomics and Integrative Biology, Delhi 110007, India. Hauptthemen laut MEDLINE: Altitude Sickness, Pulmonary Edema, Respiratory Tract Infections, Hypertension, Pulmonary. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Council of Scientific & Industrial Research.
Abstract (Originalsprache)
The dramatic changes in physiology at high altitude (HA) as a result of the characteristic hypobaric hypoxia condition can modify innate and adaptive defense mechanisms of the body. As a consequence, few sojourners visiting HA with mild or asymptomatic infection may have an enhanced susceptibility to high-altitude pulmonary edema (HAPE), an acute but severe altitude sickness. It develops upon rapid ascent to altitudes above 2500 m, in otherwise healthy individuals. Though HAPE has been studied extensively, an elaborate exploration of the HA disease burden and the potential risk factors associated with its manifestation are poorly described. The present review discusses respiratory tract infection (RTI) as an unfamiliar but important risk factor in enhancing HAPE susceptibility in sojourners for two primary reasons. First, the symptoms of RTI s resemble those of HAPE. Secondly, the imbalanced pathways contributing to vascular dysfunction in HAPE also participate in the pathogenesis of the infectious processes. These pathways have a crucial role in shaping host response against viral and bacterial infections and may further worsen the clinical outcomes at HA. Respiratory tract pathogenic agents, if screened in HAPE patients, can help in ascertaining their role in disease risk and also point toward their association with the disease severity. The microbial screenings and identifications of pathogens with diseases are the foundation for describing potential molecular mechanisms underlying host response to the microbial challenge. The prior knowledge of such infections may predict the manifestation of disease etiology and provide better therapeutic options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardio Respiratory Disease Unit, CSIR-Institute of Genomics and Integrative Biology, Delhi 110007, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
- Department of Medicine, Sonam Norboo Memorial Hospital, Leh 194101, India.
ORCID-Profile: Aastha Mishra
Förderung
- Council of Scientific & Industrial Research
Zitieren
APA
Choudhary, R., Kumari, S., Ali, M., Thinlas, T., Rabyang, S., & Mishra, A. (2024). Respiratory tract infection: an unfamiliar risk factor in high-altitude pulmonary edema. Briefings in Functional Genomics, 23(1), 38-45. https://doi.org/10.1093/bfgp/elac048
Vancouver
Choudhary R, Kumari S, Ali M, Thinlas T, Rabyang S, Mishra A. Respiratory tract infection: an unfamiliar risk factor in high-altitude pulmonary edema. Briefings in Functional Genomics. 2024;23(1):38-45. doi:10.1093/bfgp/elac048
BibTeX
@article{Choudhary2024,
author = {Choudhary, Raushni and Kumari, Swati and Ali, Manzoor and Thinlas, Tashi and Rabyang, Stanzen and Mishra, Aastha},
title = {Respiratory tract infection: an unfamiliar risk factor in high-altitude pulmonary edema},
journal = {Briefings in Functional Genomics},
year = {2024},
volume = {23},
number = {1},
pages = {38--45},
doi = {10.1093/bfgp/elac048}
}
EUVIMED